Trials / Conditions / Locally Advanced Melanoma

Locally Advanced Melanoma

11 registered clinical trials studyying Locally Advanced Melanoma — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Col NCT06626256	City of Hope Medical Center	Phase 1
Recruiting	Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in U NCT07223411	John Kirkwood	—
Recruiting	A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing NCT06066138	National Cancer Institute (NCI)	Phase 1
Recruiting	Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperab NCT06880198	Fondazione Melanoma Onlus	N/A
Active Not Recruiting	Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients NCT05176470	Richard Wu	Phase 1
Recruiting	Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Soli NCT05269381	Mayo Clinic	Phase 1 / Phase 2
Terminated	Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K Melanoma NCT04527549	ECOG-ACRIN Cancer Research Group	Phase 2
Recruiting	Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Sol NCT04771520	M.D. Anderson Cancer Center	Phase 2
Completed	Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies NCT03590054	Rahul Aggarwal	Phase 1
Recruiting	Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types NCT06075524	Mayo Clinic	—
Completed	Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer NCT01902173	National Cancer Institute (NCI)	Phase 1 / Phase 2